In a filing, Insmed Inc revealed its Chief Operating Officer Adsett Roger unloaded Company’s shares for reported $0.15 million on Jan 12 ’24. In the deal valued at $28.63 per share,5,251 shares were sold. As a result of this transaction, Adsett Roger now holds 148,559 shares worth roughly $3.8 million.
Then, Flammer Martina M.D. sold 4,667 shares, generating $133,616 in total proceeds. Upon selling the shares at $28.63, the Chief Medical Officer now owns 106,898 shares.
Before that, Adsett Roger sold 3,536 shares. Insmed Inc shares valued at $102,190 were divested by the Chief Operating Officer at a price of $28.90 per share. As a result of the transaction, Adsett Roger now holds 153,810 shares, worth roughly $3.93 million.
Truist initiated its Insmed Inc [INSM] rating to a Buy in a research note published on April 23, 2024; the price target was $48. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”an Outperform”‘ rating. Wells Fargo began covering INSM with “an Overweight” recommendation on December 08, 2023.
Price Performance Review of INSM
On Friday, Insmed Inc [NASDAQ:INSM] saw its stock fall -0.43% to $25.55. Over the last five days, the stock has gained 3.02%. Insmed Inc shares have fallen nearly -17.55% since the year began. Nevertheless, the stocks have risen 29.04% over the past one year. While a 52-week high of $32.00 was reached on 01/02/24, a 52-week low of $18.08 was recorded on 04/19/24. SMA at 50 days reached $26.77, while 200 days put it at $25.95. A total of 1.24 million shares were traded, compared to the trading of 1.5 million shares in the previous session.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 25.16, which if violated will result in even more drops to 24.76. On the upside, there is a resistance level at 26.19. A further resistance level may holdings at 26.82. The Relative Strength Index (RSI) on the 14-day chart is 46.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.39, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 41.39%. Stochastics %K at 52.75% indicates the stock is a holding.
The most recent change occurred on July 26, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
